Trial NCT02439138

View at ClinicalTrials.gov 
Org. Study IDs: 15-040
Secondary IDs: ISR IN-US-313-1609

Last trial update was posted on 2017-01-11

MeSH Interventions

Idelalisib

MeSH Conditions

Waldenstrom Macroglobulinemia

Other Conditions

Waldenstrom's Macroglobulinemia

Stopping Reasons

Safety issues from trials in CLL

Limitations And Caveats

This study was terminated early due to safety concerns from the previously untreated CLL experience. All participants who remained on study at that time were permanently removed from protocol therapy. The median time on protocol therapy was 1 cycle

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID